MoneyWorks4Me

Akums Drugs reports 58% jump in Q1 consolidated net profit

10 Aug 2026 Evaluate

Akums Drugs and Pharmaceuticals has reported results for first quarter ended June 30, 2026 (Q1FY27).

The company has reported marginal fall by 0.07% in its net profit at Rs 44.84 crore for the quarter ended June 30, 2026 as compared to Rs 44.87 crore for the same quarter in the previous year. However, total income of the company has increased by 15.90% at Rs 418.38 crore for Q1FY27 as compared to Rs 361.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 57.55% jump in its net profit at Rs 100.01 crore for Q1FY27 as compared to Rs 63.48 crore for the same quarter in the previous year. The total income of the company has increased by 13.92% at Rs 1,197.01 crore for Q1FY27 as compared to Rs 1,050.76 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..